Clinical Laboratory Improvement Amendments of 1988 (CLIA) Request for Information (RFI)

CDC
258 followers
Sep 9, 2026
During this webinar, Centers for Medicare & Medicaid Services (CMS) explains the published Clinical Laboratory Improvement Amendments (CLIA) Request for Information (RFI). The purpose of a RFI and how to submit feedback that can help inform potential updates to existing CLIA regulations are both discussed in this webinar.
AI Generated·May contain errors
Video Summary
AI GeneratedThis webinar outlines the Request for Information (RFI) CMS-3485-NC, issued by CMS and the CDC to modernize the 1988 Clinical Laboratory Improvement Amendments (CLIA). The session guides stakeholders on providing feedback regarding evolved laboratory technologies and operational models to inform future regulatory updates, with a submission deadline of September 14th.
And we're going to start. So thank you all for joining us. It's about three minutes after. We
want to make sure that we're taking care of your time. So again, thank you all for joining. My
name is Tamara McMillan and I'm a consultant with GuideHouse. I'm supporting CDC's One Lab
Initiative. A couple of notes before the webinar begin and we dive in. If you're having any
technical issues throughout, feel free to email the OneLab inbox for support at onelabatcdc.gov.
If you have any questions throughout the session, insert them into the Q&A function
and then use the Q&A icon. We'll do a Q&A session at the very end of the presentation
where we'll review your questions and do our best really to answer all of them.
We know that you all have a lot of questions. We want to make sure that we're able to get to
the questions that are pertinent. And then for those that are lingering or for those that have
other additional questions, we will have an actual email where you can send those.
Note, we're going to be posting the link to the live captions in the chat. Be sure that you keep
both of the windows open in order for it to basically play and you'll be able to use it via
the Teams webinar. So now for our agenda. So all right, my computer is doing a little thing.
All right, so we're going to be starting by discussing the OneLab resources. Then we will
go through some of the introductions. We will have a 10 minute Q&A as I just indicated at the end,
where again, we will review your questions and do our best to answer all of them.
The session today will end with a discussion of our upcoming events. So for today's webinar,
we will be leaving the chat open for your engagement. We want you to engage with your
colleagues, share things and utilize the chat for those particular purposes. Please keep in mind
the appropriate rules of engagement. Feel free to use the chat to connect with one another,
react to what you're hearing. And also please share experiences, asking questions of your
fellow participants. If you have questions for the presenter, however, please ensure that you're
using the Q&A section. Again, please ensure that you're using the Q&A function, not the chat.
The Q&A function is where we are able to ensure that we're getting all your questions and we're
able to get them to our actual presenter. Additionally, we want you to engage, but we
want you to also do that with respect and professionalism. Any inappropriate language,
improper conduct, and any forms of discrimination may result in removal from the webinar. Please
ensure your comments are relevant to the topic. And if a moderator gives you direction regarding
any chat behavior, please comply accordingly. Lastly, please notify moderators if you're
experiencing any technical difficulties or observe any disruptive behavior. Now I'm going to turn
over our session to our OneLab Network lead, Alicia Branch, to share some of the additional
resources. And she will also introduce our presenter. Alicia. Thank you, Tamera. I will
now read our external speaker disclaimer. Then, as Tamera said, I'll introduce today's speaker.
Slide decks may contain presentation material from panelists who are not affiliated with CDC.
Presentation content from external panelists may not necessarily reflect CDC's official position
on the topics covered. Next slide, please. And I'm excited to introduce our presenter today,
Mr. Bradford Belt. Bradford is a clinical laboratory scientist with the Centers for
Medicare and Medicaid Services, where he served. He served since January 2024 with more than 20
years of experience in the medical laboratory profession. Bradford has developed extensive
expertise in clinical laboratory operation, quality management, regulatory compliance,
and laboratory standards. In his current role, he supports oversight of clinical laboratories,
helping ensure compliance with federal regulations, and promoting high-quality
laboratory services. Bradford is passionate about educating laboratory professionals,
sharing practical laboratory insight, and advancing best practice that strengthens
laboratory quality and improves patient care. Over to you, Bradford. Thank you very much.
Let me share my screen. Good morning or afternoon, everyone. Thank you for joining
me for today's presentation. On the request of information for CLIA, my name is Bradford Belt.
I am with the Regulations and Clearance Branch, DCLCC, and today we're going to walk through the
RFI Federal Notice. CMS, the Centers for Medicare and Medicaid Services, and the CDC, the Centers
for Disease Control and Prevention, have jointly issued CMS 3485 NC, titled Request for Information
Clinical Laboratory Improvement Amendments of 1988 CLIA Regulations on July 16, 2026.
Today, I'll walk you through the four major topic areas covered in this RFI, highlight the specific
questions being asked, and explain how you can submit your comments. But first, this is the
standard disclaimer language. It states that this presentation is solely for informational purposes.
Please refer to the actual CLIA statute and CLIA regulations or CLIA requirements. Our objectives
for today are to explain the purpose and scope of this RFI, CMS 3485 NC, and review the process
for submitting public comments. The CLIA regulations were last comprehensively implemented
back in 1992, over 30 years ago. Since then, laboratory science has transformed dramatically,
and one of the ways to understand that transformation is through an RFI. Before we
dive in, let me clarify what an RFI is and what it is not. An RFI, a request for information,
is a formal mechanism used by federal agencies to gather input from the public and stakeholders on
various topics. It's not a proposed rule or a contracted solicitation. The government is not
committing to any specific action based on the responses. What it is is an opportunity. Responses
to this RFI may be used to inform CMS and the CDC as to what types of actions, if any, should be
taken to update the existing CLIA regulations through future notice and comment rulemaking.
Importantly, CMS will not respond to individual questions about policy issues raised in the RFI.
However, we will actively consider all input when developing future regulatory proposals
or sub-regulatory guidance. Now, this RFI is organized around four major topic areas,
breath testing, processes and procedures, emergency preparedness, biosafety, biosecurity,
and cybersecurity, and specialty testing areas. The purpose of the RFI seeks information on areas
where laboratory practices have evolved, new technologies are being used, and where the
operational models have emerged. Now, we will take a quick poll. Please take a moment to select the
best answer about RFI or proposed rulemaking. Have you ever submitted a public comment in response
to a federal notice for an RFI or proposed rule? Take a moment for you to select an answer.
Okay, it looks like most people answered no. They've never submitted comments and don't
know where to start. Oh, so D. Yes. Okay, that's good. So, this is going to be very informative
for you all. And just for just general information, the RFI and proposed rule are two formal processes
to have the public input and comments on. Now, what do we need to know about submitting your
comments? Comments must be submitted no later than September 14th. This RFI allows a 60-day
public comment period from the date of the RFI's publication in the Federal Register,
which was July 16th. The easiest way to submit your comments is electronically
at regulations.gov. Include the reference file code CMS-3485-NC in your submission.
An important note is do not include any proprietary or confidential information.
All submissions become government property and may be publicly posted. You can also go to the
RFI Federal Notice and use the Submit a Public Comment button to submit your comments. Before
we move on, I'd like to walk you through regulations.gov and federalregister.gov and
how you can find the RFI and comment on it. I will also show you how you can get notifications
from the Federal Register when any CLIA documents are published. I'm going to drag. So, here, this
is the regulations.gov. So, just take a look at this. So, see if it looks familiar. In this search
button, I am going to put in our CMS-3485-NC, and it's pretty simple. I'm going to click search
and go to dockets, and then it's going to show up there. You can also type in the docket or ID
number, which is 2026-2345, search, and it pops up again. We're just going to click on this,
and what it's going to show you is on this left side over here, it shows that there's been 17
comments that have already been posted. There's 69 comments in the work. You go to
docket documents. You can look at the RFI, if you would like, but when you want to post a comment,
you just click on the comment, and under the previous page, there was a comment button, too.
You just click on the comment, and then you're just going to fill out all this information here.
Just make sure, and if you want to opt into confirmation and submission tracking, you can.
Make sure you're not a robot, and then you're going to end up submitting. The one great thing
about this is, too, is you can also create a Word document or a PDF or any one of these
platforms, and you can just submit your questions or your answers and replies to questions that
are in the RFI in this avenue, too, so you don't have to type out anything.
So, if we move to the Federal Register, it's basically the same principle. We're going to go
search. I'm going to type in CMS-3485-NC. One match comes up, and, again, you can type in
the docket number, 2026-2345, and then, again, there's a match, and click on that,
so it's going to show one document. We'll click on that, and then the RFI is going to come up.
You can also download the RFI in a PDF. You can utilize all these tables, but if you want to
submit a public comment, you're going to come over here and click, and it's the same idea.
Add in the questions you want. Fill in this. Email. Click on this. You have read the and
understand the statement above, and then you're going to submit your comment. Again, you can also
download a file, PDF, Word doc, if you just wanted to already have your comments typed out.
Another aspect of this, too, is if you want to get notifications when anything CLIA is published,
you can go to this MyFR and sign up or sign in, and then, when you do that, there's this button
right here that's subscriptions, so let's go back to, we'll just go to search the same document,
CMS-3485-NC. We're going to click on that document. You're going to see right here,
this button says subscribe. If you click on that, it's going to allow you to subscribe to, well,
let me do this, because that's very specific. We'll just go CLIA, and you can search CLIA,
so if you search CLIA, got all these documents, then you can push subscribe, and it's going to,
anytime something that has CLIA in it, it will email that notification to you. Then, when you go
up to, let me sign in, then I'll show you where that's at. When you go into MyFR, your Create
account, when you go to My Subscriptions, it's going to pop up with CLIA, and then that is part
of your subscriptions. Anything in the Federal Register or any public document that you think
you might want to get email notifications for, you can do that as well in there. So, I hope that
helps for all you that have never submitted a comment. I apologize, I couldn't show you directly
the subscriptions. Over, and we will continue with our slideshow. All right, so again,
instructions for submitting your comments. You can submit comments one of three ways. Electronically,
like I just showed, by mail, or by express, or overnight mail. Important note, public comments
must be submitted using one of the three options. Do not send your comments to this RFI to our
Divisional General Mailbox, and again, refer to the file code CMS3485-NC with your commenting.
So, with your responses, commentators are asked to identify the specific section
and question number or numbers addressed in each portion of their submission, and to organize the
comments consistent with the structure of this RFI. For example, Section A, Breath Testing,
Question 1, or Section B, Laboratory Processes and Procedures, Subsection 2, Specimen Preparation
Activities and Personnel, Question 2. If you are submitting comments electronically, please use the
www.regulations.gov forward slash docket forward slash CMS-2026-2345. You can also just go to the
website and search like I have demonstrated in the regulations.gov or the Federal Register,
and again, you can also go to the RFI Federal Notice, Federal Register, and use the Submit a
Comment button to submit your comments when you've searched and found CMS-3485-NC or CMS-2026-2345.
Again, it will be at the top of the page on the right-hand side, and you can submit your
comments from there. If you're submitting your comments by regular mail, please mail them to
this specific address as shown here on the slide. It is also in the RFI. Remember to allow sufficient
time to mail in comments. You need that deadline, and if you're submitting your comments by express
or overnight mail, please mail them to this other address as shown here, and again, it is in the RFI.
Keep in mind the timeline. All right, before we move on to the RFI topics, I'd love to hear from
you directly. We'll launch our second and last poll question. Now, please take a moment to select
the RFI topic area that is most relevant to your laboratory practice. 118 responses.
That's pretty good. It's kind of a clear, clear topic, and so, you know, that's exactly what we
need to have that group commenting on this RFI. All right, we'll close that out. Okay, the first
topic area is breath testing, and this is a genuinely emerging frontier in clinical diagnostics.
When CLIA regulations were first promulgated in 1992, breath testing had not yet been developed
for clinical use. It was used most exclusively for law enforcement purposes and breathalyzers.
Fast forward to the COVID-19 public health emergency, and researchers and manufacturers
developed breath tests for SARS-CoV-2, sparking significant interest in expanding breath testing
clinical applications. Today, breath tests are being explored for cancer diagnoses, microbial
identification, and gastrointestinal disorders. CMS and the CDC are asking the public what breath
tests are facilities currently performing for clinical use, what methodologies and technologies
are being used, what types of facilities, for example, hospitals, GI clinics, and reference
labs are performing these tests, how are breath specimens collected, transported, and stored,
and what challenges arise. If your facility is performing or considering performing breath
testing, your input here is specifically valuable, especially valuable. All right, the next section,
laboratory processes and procedures. This section is the most expansive section of the RFI,
covering eight subsections related to laboratory operations. I'll highlight the most impactful ones.
First, pathology specimen retention. Current CLIA regulations require a minimum two years
retention period for pathology specimens. CMS is exploring whether this should be extended
and what the operational and storage implications would be for laboratories.
Number two, specimen preparation personnel. This subsection examines the qualification,
training, and competency requirements for staff involved in pre-analytical processes,
specimen preparation activities that occur before the actual test is ran.
As automation and new technologies change, who does what in the lab is the area ripe for
regulatory clarification. Suboptimal specimens, how should labs handle, document, and apply
quality assurance procedures. Specimens that don't meet ideal criteria. CMS is seeking the
best practices and input on whether current regulations adequately address this. Performance
specifications. This addresses the establishment and verification of performance specifications
for non-FDA cleared tests and modifications to clear tests, a critical area for labs running
laboratory-developed tests or LTs. Artificial intelligence in the laboratory. This is perhaps
the most forward-looking subsection. CMS is examining the use of AI for post-analytical
interpretation, meaning AI tools that assist in interpreting test results. Questions include,
how is AI currently being used? What validation is required? Who bears responsibility for AI-assisted
diagnosis? Six is remote competency assessments. The Clinical Laboratory Improvement Advisory
Committee, CLIAC, recommended in November of 2024 that CMS allowed remote technologies to be used
for the direct observation component of competency assessments. This is particularly
relevant for rules and underserved areas where in-person assessments are difficult or costly.
There's also calibration verification and data only facilities. The questions here would be,
what devices are labs using? What are the challenges? How effective is remote observation
compared to in-person? And this next section addresses three interconnected areas that
become especially prominent during the COVID-19 pandemic. Emergency preparedness. In 2026,
CMS established national emergency preparedness requirements for many healthcare providers.
But CLIA-certified independent laboratories were not included in that rule. A 2025 OIG report
recommended that CMS consider requiring independent labs participating in Medicare to have emergency
preparedness plans. Some questions being asked here, what are the best practices for lab
emergencies? Preparedness. What challenges do labs face during natural disasters, pandemics,
or power outages? What lessons were learned from recent emergencies? And so for any laboratory
directors and or managers in the audience, this is your opportunity to share what worked,
what didn't, and what you need for a regulatory framework. Next, we'll go to biosafety and
biosecurity. Current CLIA regulations require labs to establish appropriate safety procedures
and comply with applicable federal, state, or local requirements. During COVID-19, the CDC
provided extensive biosafety guidance and received numerous inquiries from labs about training
and protocols. Questions here would be, what challenges do labs face in biosafety and
biosecurity? What elements are included in current plans? And how is personnel training conducted?
Now to cybersecurity. This topic is a rapidly growing area of concern, as lab increases
increasingly rely on laboratory information systems, or LISs, or electronic health records, EHRs,
integration, automated diagnostic devices, and remote access technologies. Cybersecurity risks
have expanded significantly. Questions here would be, asked are, what cybersecurity protocols are
in place to protect patient data? How do labs respond to incidences? And who is responsible
for cybersecurity within the lab? And how is the staff trained? The final section addresses
specialty testing areas. Specific tests, specialties, subspecialties, where CLIA regulations may not
need updating to reflect technological advances in current practices. General specialty questions,
CMS is asking about challenges with existing specialties and whether with existing specialties
and whether with new specialty categories should be created, including most surgery testing or
andrology and molecular testing. Clinical cytogenetics, technology advances in chromosome
abnormality testing, including next-generation sequencing and chromosomal microarray analysis
have outpaced the original CLIA regulatory framework in this area. CMS is seeking input
on how regulations should evolve. And next is immunohematology. This subsection addresses
blood transfusion preparation and notably electronic cross-matching systems, a technology
that has become standard in many transfusion services, but may not be fully addressed
in current CLIA regulations. And lastly, microbiology. For the microbiology specialty,
CMS is focusing on blood culture contamination monitoring and quality management practices,
an area with direct patient safety implications. For specialties in any of these disciplines,
your technical expertise is exactly what CMS and the CDC need to hear. So in review,
how do you respond to this RFI? Comments must be submitted no later than September 14th.
The easiest way to submit public comments is electronically at either federalregister.gov
or regulations.gov site. Remember to reference file code CMS3485-NC for submission.
When submitting, CMS encourages you to identify the specific section and question number you
are addressing, organize your comments consistent with the structure of the RFI,
and note, do not include any proprietary or confidential information. All submissions
become government property and may be publicly posted. If you have any technical questions,
you can contact Penny Keller at CMS, penny.keller.cms.hhs.gov, or Jake D. Bunn at CDC,
jbunn.cdc.gov. And I just want to close with this. The CLIA regulations govern virtually
every clinical laboratory in the United States. They affect how tests are validated,
how personnel are trained, how specimens are handled, and ultimately, how patients
receive accurate diagnoses. The people in this virtual room today, laboratory professionals,
scientists, and clinicians, are the ones who live and work within these regulations every day.
You understand the gaps, the burdens, and the opportunities better than anyone. This RFI is
a rare and direct channel to federal regulators. Your comments can shape the next generation of
CLIA regulations, so please take the time to respond. Thank you so much for your time and
attention today. We look forward to seeing the laboratory community's voice reflected
in the future of CLIA regulations. And so now back to you, Alicia, for any questions we may have
about this RFI. Thank you again, Bradford. We'll take a few minutes to answer as many questions as
possible. If we do not get an opportunity to answer your question today, we'll do our best
to answer it by email. If you would email us at onelabatcdc.gov. Okay, let's see.
Well, I'll throw out a question. Will commenters be able to submit their comments
through the CMS mailbox? No. Commenters need to follow the instructions that are in the RFI,
and it'll be those three avenues, electronic, mail, or the expedited mail.
So what about, do you need to submit the comments to all the questions in the RFI?
No, you can pick whatever topics and questions you want to answer that pertain to you that you have
an expertise in, so we can get that form of data. But no, you don't have to answer
all the questions of every topic. Can the commenters submit a Word doc or a PDF? Which
one is better? Yeah, you can submit both, like I showed you on the regulations.gov
and the FederalRegister.gov. Instead of typing out the questions, if you're creating a Word doc
or a PDF file, you can just upload those, and it'll get through the system that way.
But it looks like that's all the questions that we have for today. Okay. I want to say thank you
again for joining us and presenting, and we're hoping that you'll be able to join us again for
another presentation. Thank you. I appreciate it. I appreciate everybody's time and ears.
Next slide, please. I'll take this time to highlight two upcoming September 1 Lab Network
events. The first event will occur on September the 16th at 12 p.m. Eastern Standard Time,
entitled Malaria Laboratory Diagnostic Testing. And then the second one will occur on September
the 23rd at 12 p.m. Eastern Standard Time, and it will be the Fundamentals of Laboratory
Director University. Once registration opens, everyone with a OneLab account will automatically
receive an email with instructions on how to register for the event. So if you do not have
a OneLab Reach account, we ask you to please use the link in the chat and go in and create a
OneLab Reach account so that you will receive the registrations for these events and all of
our future events. Next slide, please. And as a reminder that the slides and audio recording
of this event will be posted to our website within two weeks of today, and you can find
it at reach.cdc.gov slash OneLabNetwork forward slash events forward slash past events. And next
slide, please. I think that is our next slide. You can go back to the slide. And lastly, I
encourage everyone to submit your feedback about training needs. We actually use your input to
select event topics, and it helps us better understand what the community needs. Again,
the OneLab email is posted in the chat as well as on the slide. And again, I'll say thank you
for joining us today, and have a great rest of your day.
